GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » Other Current Receivables

Antengene (FRA:722) Other Current Receivables : €2.16 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Antengene Other Current Receivables?

Antengene's Other Current Receivables for the quarter that ended in Jun. 2024 was €2.16 Mil.

Antengene's quarterly Other Current Receivables increased from Jun. 2023 (€0.50 Mil) to Dec. 2023 (€2.45 Mil) but then stayed the same from Dec. 2023 (€2.45 Mil) to Jun. 2024 (€2.16 Mil).

Antengene's annual Other Current Receivables increased from Dec. 2021 (€1.03 Mil) to Dec. 2022 (€2.73 Mil) but then declined from Dec. 2022 (€2.73 Mil) to Dec. 2023 (€2.45 Mil).


Antengene Other Current Receivables Historical Data

The historical data trend for Antengene's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Other Current Receivables Chart

Antengene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial 0.58 0.54 1.03 2.73 2.45

Antengene Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 2.73 0.50 2.45 2.16

Antengene Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Antengene Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Antengene's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Antengene Business Description

Traded in Other Exchanges
Address
1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines